Molecular Mechanisms of Megakaryocyte Differentiation

Each bone marrow megakaryocyte (MK) releases thousands of platelets into the circulation, and the underlying molecular and cellular mechanisms recently have received intense scrutiny. Genetic studies are beginning to clarify the mechanisms by which transcription factors help distinguish MK progenitors from other blood cell lineages and subsequently confer unique cellular properties. Other investigations demonstrate that platelets are assembled de novo during a terminal phase of MK differentiation in which the cell extends cytoplasmic projections known as proplatelets. This review focuses on the roles of selected transcription factors with key roles in MK differentiation, and on human and murine models of thrombocytopenia that result from impaired MK differentiation. The findings we review help construct a framework to appreciate thrombopoietic mechanisms in the context of underlying lineage and morphologic transitions. Many of these mechanisms are unique to MKs but appear to rely both on genes that are expressed only in that lineage and others that are expressed widely.

KEYWORDS

Platelet - megakaryocyte - proplatelet - transcription factors - thrombopoiesis

REFERENCES

• 1 Radley J M, Scurfield G. The mechanism of platelet release.  Blood. 1980;  56 996-999
• 2 Italiano Jr J E, Lecine P, Shivdasani R A, Hartwig J H. Blood platelets are assembled principally at the ends of proplatelet processes produced by differentiated megakaryocytes.  J Cell Biol. 1999;  147 1299-1312
• 3 Shivdasani R A, Fujiwara Y, McDevitt M A, Orkin S H. A lineage-selective knockout establishes the critical role of transcription factor GATA-1 in megakaryocyte growth and platelet development.  EMBO J. 1997;  16 3965-3973
• 4 Nichols K E, Crispino J D, Poncz M et al.. Familial dyserythropoietic anaemia and thrombocytopenia due to an inherited mutation in GATA1.  Nat Genet. 2000;  24 266-270
• 5 Freson K, Devriendt K, Matthijs G et al.. Platelet characteristics in patients with X-linked macrothrombocytopenia because of a novel GATA1 mutation.  Blood. 2001;  98 85-92
• 6 Tsang A P, Fujiwara Y, Hom D B, Orkin S H. Failure of megakaryopoiesis and arrested erythropoiesis in mice lacking the GATA-1 transcriptional cofactor FOG.  Genes Dev. 1998;  12 1176-1188
• 7 Chang A N, Cantor A B, Fujiwara Y et al.. GATA-factor dependence of the multitype zinc-finger protein FOG-1 for its essential role in megakaryopoiesis.  Proc Natl Acad Sci USA. 2002;  99 9237-9242
• 8 Cantor A B, Katz S G, Orkin S H. Distinct domains of the GATA-1 cofactor FOG-1 differentially influence erythroid versus megakaryocytic maturation.  Mol Cell Biol. 2002;  22 4268-4279
• 9 Wechsler J, Greene M, McDevitt M A et al.. Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome.  Nat Genet. 2002;  32 148-152
• 10 Mundschau G, Gurbuxani S, Gamis A S, Greene M E, Arceci R J, Crispino J D. Mutagenesis of GATA1 is an initiating event in Down syndrome leukemogenesis.  Blood. 2003;  101 4298-4300
• 11 Rainis L, Bercovich D, Strehl S et al.. Mutations in exon 2 of GATA1 are early events in megakaryocytic malignancies associated with trisomy 21.  Blood. 2003;  102 981-986
• 12 Hitzler J K, Cheung J, Li Y, Scherer S W, Zipursky A. GATA1 mutations in transient leukemia and acute megakaryoblastic leukemia of Down syndrome.  Blood. 2003;  101 4301-4304
• 13 Xu G, Nagano M, Kanezaki R et al.. Frequent mutations in the GATA-1 gene in the transient myeloproliferative disorder of Down syndrome.  Blood. 2003;  102 2960-2968
• 14 Lemarchandel V, Ghysdael J, Mignotte V, Rahuel C, Romeo P H. GATA and Ets cis-acting sequences mediate megakaryocyte-specific expression.  Mol Cell Biol. 1993;  13 668-676
• 15 Deveaux S, Filipe A, Lemarchandel V, Ghysdael J, Romeo P H, Mignotte V. Analysis of the thrombopoietin receptor (MPL) promoter implicates GATA and Ets proteins in the coregulation of megakaryocyte-specific genes.  Blood. 1996;  87 4678-4685
• 16 Minami T, Tachibana K, Imanishi T, Doi T. Both Ets-1 and GATA-1 are essential for positive regulation of platelet factor 4 gene expression.  Eur J Biochem. 1998;  258 879-889
• 17 Gaines P, Geiger J N, Knudsen G, Seshasayee D, Wojchowski D M. GATA-1- and FOG-dependent activation of megakaryocytic alpha IIB gene expression.  J Biol Chem. 2000;  275 34114-34121
• 18 Holmes M L, Bartle N, Eisbacher M, Chong B H. Cloning and analysis of the thrombopoietin-induced megakaryocyte-specific glycoprotein VI promoter and its regulation by GATA-1, Fli-1, and Sp1.  J Biol Chem. 2002;  277 48333-48341
• 19 Wang X, Crispino J D, Letting D L, Nakazawa M, Poncz M, Blobel G A. Control of megakaryocyte-specific gene expression by GATA-1 and FOG-1: role of Ets transcription factors.  EMBO J. 2002;  21 5225-5234
• 20 Blobel G A, Nakajima T, Eckner R, Montminy M, Orkin S H. CREB-binding protein cooperates with transcription factor GATA-1 and is required for erythroid differentiation.  Proc Natl Acad Sci USA. 1998;  95 2061-2066
• 21 Breton-Gorius J, Favier R, Guichard J et al.. A new congenital dysmegakaryopoietic thrombocytopenia (Paris-Trousseau) associated with giant platelet alpha-granules and chromosome 11 deletion at 11q23.  Blood. 1995;  85 1805-1814
• 22 Krishnamurti L, Neglia J P, Nagarajan R et al.. Paris-Trousseau syndrome platelets in a child with Jacobsen’s syndrome.  Am J Hematol. 2001;  66 295-299
• 23 Hart A, Melet F, Grossfeld P et al.. Fli-1 is required for murine vascular and megakaryocytic development and is hemizygously deleted in patients with thrombocytopenia.  Immunity. 2000;  13 167-177
• 24 Kawada H, Ito T, Pharr P N, Spyropoulos D D, Watson D K, Ogawa M. Defective megakaryopoiesis and abnormal erythroid development in Fli-1 gene-targeted mice.  Int J Hematol. 2001;  73 463-468
• 25 Eisbacher M, Holmes M L, Newton A et al.. Protein-protein interaction between Fli-1 and GATA-1 mediates synergistic expression of megakaryocyte-specific genes through cooperative DNA binding.  Mol Cell Biol. 2003;  23 3427-3441
• 26 Rekhtman N, Radparvar F, Evans T, Skoultchi A I. Direct interaction of hematopoietic transcription factors PU.1 and GATA-1: functional antagonism in erythroid cells.  Genes Dev. 1999;  13 1398-1411
• 27 Zhang P, Behre G, Pan J et al.. Negative cross-talk between hematopoietic regulators: GATA proteins repress PU.1  Proc Natl Acad Sci USA. 1999;  96 8705-8710
• 28 Behre G, Whitmarsh A J, Coghlan M P et al.. c-Jun is a JNK-independent coactivator of the PU.1 transcription factor.  J Biol Chem. 1999;  274 4939-4946
• 29 Elagib K E, Racke F K, Mogass M, Khetawat R, Delehanty L L, Goldfarb A N. RUNX1 and GATA-1 coexpression and cooperation in megakaryocytic differentiation.  Blood. 2003;  101 4333-4341
• 30 Waltzer L, Ferjoux G, Bataille L, Haenlin M. Cooperation between the GATA and RUNX factors Serpent and Lozenge during Drosophila hematopoiesis.  EMBO J. 2003;  22 6516-6525
• 31 Song W J, Sullivan M G, Legare R D et al.. Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia.  Nat Genet. 1999;  23 166-175
• 32 Michaud J, Wu F, Osato M et al.. In vitro analyses of known and novel RUNX1/AML1 mutations in dominant familial platelet disorder with predisposition to acute myelogenous leukemia: implications for mechanisms of pathogenesis.  Blood. 2002;  99 1364-1372
• 33 Mucenski M L, McLain K, Kier A B et al.. A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis.  Cell. 1991;  65 677-689
• 34 Emambokus N, Vegiopoulos A, Harman B, Jenkinson E, Anderson G, Frampton J. Progression through key stages of haemopoiesis is dependent on distinct threshold levels of c-Myb.  EMBO J. 2003;  22 4478-4488
• 35 Kasper L H, Boussouar F, Ney P A et al.. A transcription-factor-binding surface of coactivator p300 is required for haematopoiesis.  Nature. 2002;  419 738-743
• 36 Takahashi T, Suwabe N, Dai P, Yamamoto M, Ishii S, Nakano T. Inhibitory interaction of c-Myb and GATA-1 via transcriptional co-activator CBP.  Oncogene. 2000;  19 134-140
• 37 Lecine P, Blank V, Shivdasani R. Characterization of the hematopoietic transcription factor NF-E2 in primary murine megakaryocytes.  J Biol Chem. 1998;  273 7572-7578
• 38 Shavit J A, Motohashi H, Onodera K, Akasaka J, Yamamoto M, Engel J D. Impaired megakaryopoiesis and behavioral defects in mafG-null mutant mice.  Genes Dev. 1998;  12 2164-2174
• 39 Onodera K, Shavit J A, Motohashi H, Yamamoto M, Engel J D. Perinatal synthetic lethality and hematopoietic defects in compound mafG::mafK mutant mice.  EMBO J. 2000;  19 1335-1345
• 40 Shivdasani R A, Rosenblatt M F, Zucker-Franklin D et al.. Transcription factor NF-E2 is required for platelet formation independent of the actions of thrombopoietin/MGDF in megakaryocyte development.  Cell. 1995;  81 695-704
• 41 Lecine P, Villeval J L, Vyas P, Swencki B, Xu Y, Shivdasani R A. Mice lacking transcription factor NF-E2 provide in vivo validation of the proplatelet model of thrombocytopoiesis and show a platelet production defect that is intrinsic to megakaryocytes.  Blood. 1998;  92 1608-1616
• 42 Levin J, Peng J P, Baker G R et al.. Pathophysiology of thrombocytopenia and anemia in mice lacking transcription factor NF-E2.  Blood. 1999;  94 3037-3047
• 43 Vyas P, Ault K, Jackson C W, Orkin S H, Shivdasani R A. Consequences of GATA-1 deficiency in megakaryocytes and platelets.  Blood. 1999;  93 2867-2875
• 44 Lecine P, Italiano Jr J E, Kim S W, Villeval J L, Shivdasani R A. Hematopoietic-specific beta 1 tubulin participates in a pathway of platelet biogenesis dependent on the transcription factor NF-E2.  Blood. 2000;  96 1366-1373
• 45 Nagata Y, Yoshikawa J, Hashimoto A, Yamamoto M, Payne A H, Todokoro K. Proplatelet formation of megakaryocytes is triggered by autocrine-synthesized estradiol.  Genes Dev. 2003;  17 2864-2869
• 46 Schwer H D, Lecine P, Tiwari S, Italiano Jr J E, Hartwig J H, Shivdasani R A. A lineage-restricted and divergent beta-tubulin isoform is essential for the biogenesis, structure and function of blood platelets.  Curr Biol. 2001;  11 579-586
• 47 Italiano Jr J E, Bergmeier W, Tiwari S et al.. Mechanisms and implications of platelet discoid shape.  Blood. 2003;  101 4789-4796
• 48 Shiraga M, Ritchie A, Aidoudi S et al.. Primary megakaryocytes reveal a role for transcription factor NF-E2 in integrin alpha IIb beta 3 signaling.  J Cell Biol. 1999;  147 1419-1430
• 49 Tiwari S, Italiano J E, Barral D C et al.. A role for Rab27b in NF-E2-dependent pathways of platelet formation.  Blood. 2003;  102 3970-3979
• 50 Novak E K, Reddington M, Zhen L et al.. Inherited thrombocytopenia caused by reduced platelet production in mice with the gunmetal pigment gene mutation.  Blood. 1995;  85 1781-1789
• 51 Detter J C, Zhang Q, Mules E H et al.. Rab geranylgeranyl transferase alpha mutation in the gunmetal mouse reduces Rab prenylation and platelet synthesis.  Proc Natl Acad Sci USA. 2000;  97 4144-4149
• 52 Ihara K, Ishii E, Eguchi M et al.. Identification of mutations in the c-mpl gene in congenital amegakaryocytic thrombocytopenia.  Proc Natl Acad Sci USA. 1999;  96 3132-3136
• 53 van den Oudenrijn S, Bruin M, Folman C C et al.. Mutations in the thrombopoietin receptor, Mpl, in children with congenital amegakaryocytic thrombocytopenia.  Br J Haematol. 2000;  110 441-448
• 54 Ballmaier M, Germeshausen M, Schulze H et al.. c-mpl mutations are the cause of congenital amegakaryocytic thrombocytopenia.  Blood. 2001;  97 139-146
• 55 Ballmaier M, Schulze H, Strauss G et al.. Thrombopoietin in patients with congenital thrombocytopenia and absent radii: elevated serum levels, normal receptor expression, but defective reactivity to thrombopoietin.  Blood. 1997;  90 612-619
• 56 Letestu R, Vitrat N, Masse A et al.. Existence of a differentiation blockage at the stage of a megakaryocyte precursor in the thrombocytopenia and absent radii (TAR) syndrome.  Blood. 2000;  95 1633-1641
• 57 Kelley M J, Jawien W, Ortel T L, Korczak J F. Mutation of MYH9, encoding non-muscle myosin heavy chain A, in May-Hegglin anomaly.  Nat Genet. 2000;  26 106-108
• 58 Kunishima S, Kojima T, Matsushita T et al.. Mutations in the NMMHC-A gene cause autosomal dominant macrothrombocytopenia with leukocyte inclusions (May-Hegglin anomaly/Sebastian syndrome).  Blood. 2001;  97 1147-1149
• 59 Seri M, Pecci A, Di Bari F et al.. MYH9-related disease: May-Hegglin anomaly, Sebastian syndrome, Fechtner syndrome, and Epstein syndrome are not distinct entities but represent a variable expression of a single illness.  Medicine (Baltimore). 2003;  82 203-215
• 60 Lopez J A, Andrews R K, Afshar-Kharghan V, Berndt M C. Bernard-Soulier syndrome.  Blood. 1998;  91 4397-4418
• 61 White J G, Gerrard J M. Ultrastructural features of abnormal blood platelets. A review.  Am J Pathol. 1976;  83 589-632
• 62 Hayward C P, Cramer E M, Kane W H et al.. Studies of a second family with the Quebec platelet disorder: evidence that the degradation of the alpha-granule membrane and its soluble contents are not secondary to a defect in targeting proteins to alpha-granules.  Blood. 1997;  89 1243-1253
• 63 Gurney A L, Carver-Moore K, de Sauvage F J, Moore M W. Thrombocytopenia in c-mpl-deficient mice.  Science. 1994;  265 1445-1447
• 64 Carver-Moore K, Broxmeyer H E, Luoh S M et al.. Low levels of erythroid and myeloid progenitors in thrombopoietin- and c-mpl-deficient mice.  Blood. 1996;  88 803-808
• 65 Alexander W S, Roberts A W, Nicola N A, Li R, Metcalf D. Deficiencies in progenitor cells of multiple hematopoietic lineages and defective megakaryocytopoiesis in mice lacking the thrombopoietic receptor c-Mpl.  Blood. 1996;  87 2162-2170
• 66 Bunting S, Widmer R, Lipari T et al.. Normal platelets and megakaryocytes are produced in vivo in the absence of thrombopoietin.  Blood. 1997;  90 3423-3429
• 67 Zeigler F C, de Sauvage F, Widmer H R et al.. In vitro megakaryocytopoietic and thrombopoietic activity of c-mpl ligand (TPO) on purified murine hematopoietic stem cells.  Blood. 1994;  84 4045-4052
• 68 Kirito K, Osawa M, Morita H et al.. A functional role of Stat3 in in vivo megakaryopoiesis.  Blood. 2002;  99 3220-3227
• 69 Kimura Y, Hart A, Hirashima M et al.. Zinc finger protein, Hzf, is required for megakaryocyte development and hemostasis.  J Exp Med. 2002;  195 941-952
• 70 Mikkola H K, Klintman J, Yang H et al.. Haematopoietic stem cells retain long-term repopulating activity and multipotency in the absence of stem-cell leukaemia SCL/tal-1 gene.  Nature. 2003;  421 547-551
• 71 Hall M A, Curtis D J, Metcalf D et al.. The critical regulator of embryonic hematopoiesis, SCL, is vital in the adult for megakaryopoiesis, erythropoiesis, and lineage choice in CFU-S12.  Proc Natl Acad Sci USA. 2003;  100 992-997
• 72 Zucker-Franklin D. Atlas of Blood Cells: Function and Pathology, Vol 2. Philadelphia; Lea & Febiger 1988
• 73 Emambokus N R, Frampton J. The glycoprotein IIb molecule is expressed on early murine hematopoietic progenitors and regulates their numbers in sites of hematopoiesis.  Immunity. 2003;  19 33-45
• 74 Mikkola H K, Fujiwara Y, Schlaeger T M, Traver D, Orkin S H. Expression of CD41 marks the initiation of definitive hematopoiesis in the mouse embryo.  Blood. 2003;  101 508-516
• 75 Nakorn T N, Miyamoto T, Weissman I L. Characterization of mouse clonogenic megakaryocyte progenitors.  Proc Natl Acad Sci USA. 2003;  100 205-210
• 76 Debili N, Coulombel L, Croisille L et al.. Characterization of a bipotent erythro-megakaryocytic progenitor in human bone marrow.  Blood. 1996;  88 1284-1296
• 77 Kaushansky K. Thrombopoietin: the primary regulator of platelet production.  Blood. 1995;  86 419-431
• 78 Choi E S, Hokom M M, Chen J L et al.. The role of megakaryocyte growth and development factor in terminal stages of thrombopoiesis.  Br J Haematol. 1996;  95 227-233
• 79 Odell Jr T T, Jackson C W. Polyploidy and maturation of rat megakaryocytes.  Blood. 1968;  32 102-110
• 80 Raslova H, Roy L, Vourc’h C et al.. Megakaryocyte polyploidization is associated with a functional gene amplification.  Blood. 2003;  101 541-544
• 81 Nagata Y, Muro Y, Todokoro K. Thrombopoietin-induced polyploidization of bone marrow megakaryocytes is due to a unique regulatory mechanism in late mitosis.  J Cell Biol. 1997;  139 449-457
• 82 Wang Z, Zhang Y, Kamen D, Lees E, Ravid K. Cyclin D3 is essential for megakaryocytopoiesis.  Blood. 1995;  86 3783-3788
• 83 Matsumura I, Tanaka H, Kawasaki A et al.. Increased D-type cyclin expression together with decreased cdc2 activity confers megakaryocytic differentiation of a human thrombopoietin-dependent hematopoietic cell line.  J Biol Chem. 2000;  275 5553-5559
• 84 Carow C E, Fox N E, Kaushansky K. Kinetics of endomitosis in primary murine megakaryocytes.  J Cell Physiol. 2001;  188 291-303
• 85 Garcia P, Frampton J, Ballester A, Cales C. Ectopic expression of cyclin E allows non-endomitotic megakaryoblastic K562 cells to establish re-replication cycles.  Oncogene. 2000;  19 1820-1833
• 86 Bermejo R, Vilaboa N, Cales C. Regulation of CDC6, geminin, and CDT1 in human cells that undergo polyploidization.  Mol Biol Cell. 2002;  13 3989-4000
• 87 Geng Y, Yu Q, Sicinska E et al.. Cyclin E ablation in the mouse.  Cell. 2003;  114 431-443
• 88 Heijnen H F, Debili N, Vainchencker W, Breton-Gorius J, Geuze H J, Sixma J J. Multivesicular bodies are an intermediate stage in the formation of platelet alpha-granules.  Blood. 1998;  91 2313-2325
• 89 Youssefian T, Cramer E M. Megakaryocyte dense granule components are sorted in multivesicular bodies.  Blood. 2000;  95 4004-4007
• 90 Rojnuckarin P, Kaushansky K. Actin reorganization and proplatelet formation in murine megakaryocytes: the role of protein kinase Cα.  Blood. 2001;  97 154-161
• 91 De Botton S, Sabri S, Daugas E et al.. Platelet formation is the consequence of caspase activation within megakaryocytes.  Blood. 2002;  100 1310-1317
• 92 Ogilvy S, Metcalf D, Print C G, Bath M L, Harris A W, Adams J M. Constitutive Bcl-2 expression throughout the hematopoietic compartment affects multiple lineages and enhances progenitor cell survival.  Proc Natl Acad Sci USA. 1999;  96 14943-14948
• 93 Kaluzhny Y, Yu G, Sun S et al.. BclxL overexpression in megakaryocytes leads to impaired platelet fragmentation.  Blood. 2002;  100 1670-1678
• 94 Bouillet P, Metcalf D, Huang D C et al.. Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity.  Science. 1999;  286 1735-1738
• 95 Clarke M C, Savill J, Jones D B, Noble B S, Brown S B. Compartmentalized megakaryocyte death generates functional platelets committed to caspase-independent death.  J Cell Biol. 2003;  160 577-587
• 96 Hitchcock I S, Skerry T M, Howard M R, Genever P G. NMDA receptor-mediated regulation of human megakaryocytopoiesis.  Blood. 2003;  102 1254-1259
• 97 Delehanty L L, Mogass M, Gonias S L, Racke F K, Johnstone B, Goldfarb A N. Stromal inhibition of megakaryocytic differentiation is associated with blockade of sustained Rap1 activation.  Blood. 2003;  101 1744-1751
• 98 de Bruyn K M, Zwartkruis F J, de Rooij J, Akkerman J W, Bos J L. The small GTPase Rap1 is activated by turbulence and is involved in integrin [alpha]IIb[beta]3-mediated cell adhesion in human megakaryocytes.  J Biol Chem. 2003;  278 22412-22417
• 99 Eto K, Murphy R, Kerrigan S W et al.. Megakaryocytes derived from embryonic stem cells implicate CalDAG-GEFI in integrin signaling.  Proc Natl Acad Sci USA. 2002;  99 12819-12824
• 100 Battinelli E, Willoughby S R, Foxall T, Valeri C R, Loscalzo J. Induction of platelet formation from megakaryocytoid cells by nitric oxide.  Proc Natl Acad Sci USA. 2001;  98 14458-14463